Injection Drug Use and Hepatitis C

7/5/02


Click here to start


Table of Contents

Injection Drug Use and Hepatitis C

Why Does Injection Drug Use Matter?

Overview: Key Questions

Overview: Key Questions

Recommendations

Risk-Benefit Considerations

Risk-Benefit Considerations

Adherence by IDUs to Medical Treatments

HIV Treatment Guidelines on Adherence

HCV Rx in IDUs Entering Opiate Detoxification (N=50)

HCV Rx in IDUs Entering Opiate Detoxification (N=50)

Methadone Patients Treated for HCV (N=66)

Methadone Patients Treated for HCV (N=66)

Methadone Patients Treated for HCV (N=66)

Reinfection in IDUs Successfully Treated for HCV

Recommendations

Recommendations

Recommendations

Recommendations

Recommendations

Acknowledgement

USPHS* Medical Advice For Persons Who Inject Illicit Drugs

Principles for Managing Health Care Relationships With Substance-Using Patients

Principles for Managing Health Care Relationships With Substance-Using Patients

Principles for Managing Health Care Relationships With Substance-Using Patients

Principles for Managing Health Care Relationships With Substance-Using Patients

Effective Strategies for Improving Adherence

HIV Treatment Guidelines Statement on Adherence

Prevention and Treatment of Infectious Diseases With Substance-Using Patients

Prevention and Treatment of Infectious Diseases With Substance-Using Patients

Prevention and Treatment of Infectious Diseases With Substance-Using Patients

Author: Brian Edlin

Email: webmaster@harmreduction.org

Home Page: http://itsa.ucsf.edu/~uhs/

Download presentation source